S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights|
|Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting|
|Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual Meeting|
|Sunesis Pharmaceuticals to Host Conference Call and Slide Webcast Tuesday, December 9 Following Presentation of Phase 3 VALOR Trial Results at ASH Annual Meeting|
|Sunesis Pharma shares crater after failed cancer drug trial|
|Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia|
|Sunesis Announces Publication of REVEAL-1 Trial Results in the British Journal of Haematology|
|Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica|
|Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference|
|Sunesis to Present at Upcoming Investor Conferences|
Click above to view more mutual fund data and stats for snss - Sunesis Pharmaceuticals Inc.